PMPRB rules that Horizon Pharma must cut 'excessive' prices for life-saving drug
Horizon Pharma will be forced to lower the price on its life-saving Procysbi medication, after the Patented Medicines Prices Review Board (PMPRB) decided the $300,000-a-year drug was too expensive.